Short- and long-term responses to molybdenum-99 shortages in nuclear medicine.
Br J Radiol
; 83(995): 899-901, 2010 Nov.
Article
in En
| MEDLINE
| ID: mdl-20965898
Most nuclear medicine studies use (99)Tc(m), which is the decay product of (99)Mo. The world supply of (99)Mo comes from only five nuclear research reactors and availability has been much reduced in recent times owing to problems at the largest reactors. In the short-term there are limited actions that can be taken owing to capacity issues on alternative imaging modalities. In the long-term, stability of (99)Mo supply will rely on a combination of replacing conventional reactors and developing new technologies.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Radioisotopes
/
Molybdenum
/
Nuclear Medicine
Limits:
Humans
Language:
En
Journal:
Br J Radiol
Year:
2010
Document type:
Article
Country of publication:
United kingdom